Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes
Recruiting · NCT04583800 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital, Lille
View the official record on ClinicalTrials.gov →What this trial is about
Type 2 diabetes is a risk factor of heart failure and cognitive decline. Heart failure at its early stage is often silent. At present, primary prevention for heart failure is not available. Our aim is to identify diabetic patients at risk of heart failure in order to develop personalized preventive strategies. Type 2 diabetes is vascular and metabolic risk factor for cognitive decline though a direct lesional effect but also through an interaction with underlying neurodegenerative lesions. Our aim is to identify diabetic patients at risk of cognitive decline in order to develop personalized preventive strategies
Who can take part
Inclusion criteria
- Adults
- Persons able to understand and object to the information provided.
- Type 2 diabetic patient free of heart failure ≥stade B
- Patient affiliated with a social security scheme.
- Patient agreeing to sign the informed consent form
Exclusion criteria
- Patient with dementia
- Patient with at least one of the criteria for heart failure ≥stade B
Where it is running
1 location listed.
- Hopital Roger Salengro, CHU Lille - Lille, France